Medicare Moves to Eliminate the Inpatient‑Only List: What Providers Need to Know

For more than two decades, Medicare’s Inpatient‑Only (IPO) List served as a regulatory guardrail, clearly identifying which surgical procedures were payable only when performed in the inpatient hospital setting. If a procedure appeared on the list, Medicare would deny payment when billed as outpatient—regardless of clinical circumstances.

That certainty is coming to an end.

In the Calendar Year (CY) 2026 Outpatient Prospective Payment System (OPPS) Final Rule, the Centers for Medicare & Medicaid Services (CMS) finalized a plan to phase out the Inpatient‑Only List entirely, completing its elimination by January 1, 2028. [acdis.org], [bpdhealthcare.com]

This change represents a major shift in how surgical care is evaluated, documented, and reimbursed under Medicare.

What Is the Inpatient‑Only List?

The IPO List was created in 2000 and updated annually through the OPPS rulemaking process. It included roughly 1,700–1,800 CPT® and HCPCS codes for procedures CMS believed were too complex, high‑risk, or resource‑intensive to be safely performed in the outpatient setting. [medcitynews.com], [racmonitor...dlearn.com]

Historically, IPO status mattered because it:

• Guaranteed inpatient payment under Medicare Part A

• Exempted cases from Two‑Midnight Rule medical review

• Offered protection against site‑of‑service denials

Once a procedure was removed from the IPO List, hospitals faced greater scrutiny to justify inpatient status.

CMS’s Phase‑Out Timeline (2026–2028)

CMS finalized a three‑year phase‑out of the IPO List under the CY 2026 OPPS Final Rule: [acdis.org], [bpdhealthcare.com]

Key Dates:

• January 1, 2026:

  • 285 procedures removed from the IPO List

  • Primarily musculoskeletal surgeries (orthopedic and spine), plus select cardiovascular and other procedures

• CY 2027:

  • Remaining IPO procedures removed in groups

• January 1, 2028:

  • The IPO List is fully eliminated

During the transition, procedures removed from the IPO List are temporarily exempt from Two‑Midnight medical review, until CMS determines they are more commonly performed in outpatient settings. [acdis.org]

Why CMS Is Eliminating the IPO List

CMS cites several drivers behind this policy shift:

• Advancements in surgical techniques (minimally invasive procedures)

• Improved anesthesia and pain management

• Shorter recovery times

• Growth of outpatient and ambulatory surgery centers (ASCs)

• Lower overall Medicare costs for outpatient care [humanmedic...illing.com], [hhs.gov]

CMS frames the elimination as a modernization effort—giving physicians greater flexibility to determine the most clinically appropriate setting for care.

IPO Elimination Does Not Mean “Outpatient by Default”

One of the most critical (and often misunderstood) points is this:

Removal from the IPO List does NOT automatically mean outpatient care is appropriate.

CMS explicitly states that inpatient admission may still be justified based on:

• Patient comorbidities

• Surgical complexity

• Anticipated complications

• Need for extended monitoring or hospital resources

In fact, CMS warns that it would be a misinterpretation of Medicare policy to treat outpatient as the default site of service solely because a procedure is no longer on the IPO List. [medlearn.com], [racmonitor...dlearn.com]

Financial and Compliance Implications for Providers

While the elimination increases flexibility, it also shifts risk from CMS to providers.

Key Impacts:

• Increased documentation burden to support inpatient status

• Higher exposure to audits and post‑payment denials

• Greater reliance on Two‑Midnight Rule compliance

• Potential revenue loss if inpatient admissions are downgraded

Without the categorical protection of the IPO List, inpatient payment hinges on patient‑specific medical necessity, not the procedure itself. [medcitynews.com], [racmonitor...dlearn.com]

What Hospitals and Coders Should Do Now

To prepare for the IPO List’s elimination, organizations should:

• Update inpatient admission criteria and pathways

• Strengthen physician education on documentation requirements

• Align utilization review processes with Two‑Midnight Rule expectations

• Monitor payer behavior—commercial payers often follow Medicare’s lead

• Track IPO‑removed procedures separately for audit risk and financial impact

Early preparation is essential to avoid unnecessary denials and appeals as CMS transitions fully away from procedural “safe harbors.”

The Bottom Line

CMS’s decision to eliminate the Medicare Inpatient‑Only List by 2028 is one of the most significant site‑of‑service policy shifts in years. While it offers flexibility and recognizes modern surgical advances, it also replaces clarity with case‑by‑case judgment, documentation rigor, and audit risk.

For providers, success in this new landscape will depend less on what procedure is performed—and far more on how well the patient’s inpatient need is documented and defended.